KK8123
8123-001
Phase 1 small_molecule active
Quick answer
KK8123 for X-linked hypophosphatemia. is a Phase 1 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KYOWA KIRIN AUSTRALIA PTY LTD
- Indication
- X-linked hypophosphatemia.
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active